We look forward to meeting you at the Dutch ATMP Summit 2026 in the Netherlands on 11 March 2026
Get ready to explore the next era of advanced therapy production at the Dutch ATMP Summit 2026! This year’s theme, “ATMP 2030: Future-Proofing Advanced Therapy Manufacturing,” puts CMC, GMP, and real-world manufacturing challenges at the heart of the program.
As the ATMP field accelerates, the demand for safe, consistent, and scalable production is greater than ever. Industry leaders will reveal what must change in manufacturing, analytics, digitalization, and regulatory frameworks to ensure next-generation therapies can reach patients efficiently and reliably.
Join top experts from CBG-MEB (regulators), Fuse Vectors, LUMC, Ntrans Technologies, Solvias, Zelluna, Progress – Experts in Life Sciences and others as they deliver high-impact insights across four pillars: production innovation, advanced analytics & QC, translational development, and regulatory future outlook. You’ll dive into real-world case studies, emerging technologies, and future-shaping strategies that will define the ATMP landscape toward 2030.
Securecell AG will showcase its latest innovations for bioprocess automation and digitization solutions that help researchers accelerate the development of new products, increase manufacturing productivity, and improve efficiency in all phases of development.
To schedule an insightful conversation, please reach out to our representatives and arrange your in-person meeting with Mohi Ahmadinia through the form here.
For more information on the event and to register, please visit here.
